Table 1. Patient and healthy subject characteristics.
| Characteristics | Hepatitis C virus-related chronic liver disease | Healthy subjects | p-value |
| (n = 69) | (n = 50) | ||
| Age (years) | 60.4±11.3 | 59.6±6.69 | p = 0.35 |
| Sex (M/F) | 32/37 | 27/23 | p = 0.41 |
| BMI (Kg/m2) | 23.2±3.27 | 22.4±2.59 | p = 0.35 |
| AST (IU/L) | 52.0±30.3 | 23.1±5.27 | p<0.000000000001 |
| ALT (IU/L) | 46.6±33.0 | 20.3±7.54 | p<0.00000001 |
| total CHO | 156.2±36.9 | 213.0±28.8 | p<0.000000000001 |
| total TG | 88.3±37.0 | 106.3±54.8 | p = 0.08 |
| Serotype, n | |||
| Group 1 | 51 | ||
| Group 2 | 13 | ||
| Unclassified | 5 | ||
| Fibrosis, n | |||
| F 0 | 0 | ||
| F 1 | 17 | ||
| F 2 | 10 | ||
| F 3 | 20 | ||
| F 4 | 22 | ||
p-values, when shown in italics such as p<0.01, indicate that there are significant differences. Values are shown as mean ± SD (standard deviation). BMI; Body Mass Index, AST; Aspartate transaminase, ALT; Alanine transaminase, CHO; cholesterol, TG; triglyceride.